A Year in Review and a Look to the Future: BTKi in CLL and MCL
CCO Oncology Podcast - Un pódcast de Clinical Care Options
Categorías:
Expert faculty discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the past year, as well as anticipated data from ASH 2023 and the current and potential impact on practice.
